Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Scopus Biopharma Inc
(NQ:
SCPS
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 16, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Scopus Biopharma Inc
< Previous
1
2
3
4
5
6
Next >
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer
November 07, 2023
From
Scopus BioPharma Inc.
Via
GlobeNewswire
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
November 02, 2023
From
Scopus BioPharma Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 29, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 27, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 26, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 23, 2022
Via
Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
December 22, 2022
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 22, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 20, 2022
Via
Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
December 19, 2022
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
December 19, 2022
On Monday, 297 companies reached new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 19, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 16, 2022
Via
Benzinga
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
December 16, 2022
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 16, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 16, 2022
Via
Benzinga
Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket
December 16, 2022
Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 16, 2022
We're starting off the final trading day this week with a look at the biggest pre-market stock movers to watch for Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
December 15, 2022
Via
Benzinga
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session
December 15, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 15, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 15, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
December 15, 2022
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!
Via
InvestorPlace
Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket
December 15, 2022
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday.
Via
Benzinga
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket
December 14, 2022
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 09, 2022
Via
Benzinga
Why iBio Shares Are Trading Lower By Around 48%; Here Are 23 Stocks Moving Premarket
December 07, 2022
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 71.3% to $0.7190 in pre-market trading after the company reported withdrawal of registration statement.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
December 07, 2022
It's time for another dive into the biggest pre-market stock movers as we check out the latest news traders need to know about on Wednesday!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.